Advertisement

'Tattoo' star Rapace snags Hollywood role

The Local Sweden
The Local Sweden - [email protected]
'Tattoo' star Rapace snags Hollywood role

Swedish actress Noomi Rapace has landed the lead female role in a major Hollywood feature following her much acclaimed screen portrayal of Lisbeth Salander from Stieg Larsson’s “Millenium” crime novels.

Advertisement

The 30-year-old actress from Hudiksvall in eastern Sweden has been signed by Warner Bros. studios to play opposite Robert Downey Jr. and Jude Law in “Sherlock Holmes 2”, The Hollywood Reporter reports.

Rapace’s first English speaking film role “remains shrouded in mystery”, according to the newspaper, citing some sources claiming the Swedish actress may be playing a French Gypsy.

The film will be directed by Guy Ritchie, who also directed the first installment of the Sherlock Holmes series, which grossed more than $520 million worldwide.

Rapace took home Best Actress honours at the Swedish film awards in January for her portrayal of the brooding Salander.

Her performance also caused American film critics to swoon when the first installment of the Swedish version of the Millennium films hit US theatres.

“I can't think of an American actress who could play Lisbeth...Someone able to play hard as nails and emotionally unavailable. Make her a Swede, and simply cast Noomi Rapace,” Chicago Sun Times star critic Roger Ebert said at the time.

In August, it was announced that Rooney Mara, a relative Hollywood unknown, would be cast as Salander in the English-language version of the first film, “The Girl with the Dragon Tattoo”, which is due to be released in December 2011, the same time as “Sherlock Holmes 2” is scheduled for release.

More

Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also